comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 15:39:53 - browse：69

Golden brain and DNA spiral illustration. -- biotech coverage from STAT — Adobe

The dream of being able to pluck a cell therapy off of a freezer shelf and speedily give it to cancer patients is materializing in the cancer world. Now, a new biotech hopes to do the same for patients with neurological conditions.

Kenai Therapeutics closed a $82 million Series A round Thursday co-led by Cure Ventures, The Column Group, and sovereign wealth fund Alaska Permanent Fund Corp. The San Diego-based biotech has big plans for that money — it’s already identified its lead drug candidate for people with Parkinson’s disease, and plans to move into a clinical trial within the next year.

Kenai — pronounced key-nigh — is developing therapies that use induced pluripotent stem cells, or iPSCs. These highly versatile organisms are derived from skin or blood cells and can be transformed into any type of cell. In Parkinson’s, the idea is that these cells would replace damaged neurons.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

WSS

FDA warns medical device makers about rise in fabricated data

Surprise medical billing ban raises prices elsewhere

Oral obesity drug from Viking Therapeutics hits key early target

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Young boy dies in trial for Pfizer Duchenne gene therapy

Oral obesity drug from Viking Therapeutics hits key early target

Wikipedia

comprehensive

hotspot

Hollywood unions extend contract negotiations for actors

First Opinion on colorectal cancer screening: letter and response

Walensky prepares to leave CDC — and Congress — behind

Surprise medical billing ban raises prices elsewhere

Jerome Adams on the need for new antivirals for Covid

As AI regulations shape up, health tech startups beg for clarity

Affirmative action in medical school literally saved lives

Florida Supreme Court upholds state's abortion ban

After affirmative action ruling, medical educators look to 'holistic review'

People with mental disorders often marry others with same

explore

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Young boy dies in trial for Pfizer Duchenne gene therapy

Ukraine seeks to reclaim its role as a hub for clinical trials

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Covid silver lining: Unprecedented look at human immune system

focus

hotspot

leisure time

Wikipedia